Single-port Laparoscopy in Children and Adolescents
Advantages of Single-port Laparoscopy in the Treatment of Benign Ovarian Tumors in Children and Adolescents: A Multicenter Retrospective Study
1 other identifier
observational
300
1 country
1
Brief Summary
To compare the safety evaluation, efficacy evaluation, long-term aesthetics and psychological satisfaction of single-port and multiport laparoscopy for children and adolescents with BOT in China.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedFirst Submitted
Initial submission to the registry
December 9, 2023
CompletedFirst Posted
Study publicly available on registry
January 11, 2024
CompletedJanuary 11, 2024
December 1, 2023
4 years
December 9, 2023
December 29, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Operation duration
The time elapsed from the initial incision to final skin closure
3 hours
Secondary Outcomes (2)
The Visual Analog Scale (VAS) score
24 hours after surgery
5-point Likert scale
1 month and 1 year after surgery
Study Arms (2)
Single-port Laparoscopy group
Single-port Laparoscopy in the Treatment of Benign Ovarian Tumors in Children and Adolescents
Multiport Laparoscopy group
Multiport Laparoscopy in the Treatment of Benign Ovarian Tumors in Children and Adolescents
Interventions
The two groups underwent different surgical procedures.
The two groups underwent different surgical procedures.
Eligibility Criteria
All patients aged ≤18 years and pathologically diagnosed with BOT were collected from the electronic medical records of six gynecological oncology medical centers in Fujian, China between January 2019 and January 2023.
You may qualify if:
- Patients ≤18 years old
- Postoperative pathological diagnosis confirmed benign ovarian tumor
- Multi-hole laparoscopic or single-hole laparoscopic surgery
- Medical records and pathological data were complete and available
You may not qualify if:
- Patients with malignant pathological diagnosis
- Patients undergoing open surgery
- Incomplete medical records or pathological data
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fujian Maternal and Child Health Hospital
Fuzhou, Fujian, 350001, China
Study Officials
- PRINCIPAL INVESTIGATOR
Pengming Sun, Ph.D
Fujian Maternity and Child Health Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
December 9, 2023
First Posted
January 11, 2024
Study Start
January 1, 2019
Primary Completion
January 1, 2023
Study Completion
December 1, 2023
Last Updated
January 11, 2024
Record last verified: 2023-12